Genomics of an endemic cystic fibrosis Burkholderia multivorans strain reveals low within-patient evolution but high between-patient diversity.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
03 2021
Historique:
received: 27 11 2020
accepted: 22 02 2021
revised: 25 03 2021
pubmed: 16 3 2021
medline: 27 7 2021
entrez: 15 3 2021
Statut: epublish

Résumé

Burkholderia multivorans is a member of the Burkholderia cepacia complex (Bcc), notorious for its pathogenicity in persons with cystic fibrosis. Epidemiological surveillance suggests that patients predominantly acquire B. multivorans from environmental sources, with rare cases of patient-to-patient transmission. Here we report on the genomic analysis of thirteen isolates from an endemic B. multivorans strain infecting four cystic fibrosis patients treated in different pediatric cystic fibrosis centers in Belgium, with no evidence of cross-infection. All isolates share an identical sequence type (ST-742) but whole genome analysis shows that they exhibit peculiar patterns of genomic diversity between patients. By combining short and long reads sequencing technologies, we highlight key differences in terms of small nucleotide polymorphisms indicative of low rates of adaptive evolution within patient, and well-defined, hundred kbps-long segments of high enrichment in mutations between patients. In addition, we observed large structural genomic variations amongst the isolates which revealed different plasmid contents, active roles for transposase IS3 and IS5 in the deactivation of genes, and mobile prophage elements. Our study shows limited within-patient B. multivorans evolution and high between-patient strain diversity, indicating that an environmental microdiverse reservoir must be present for this endemic strain, in which active diversification is taking place. Furthermore, our analysis also reveals a set of 30 parallel adaptations across multiple patients, indicating that the specific genomic background of a given strain may dictate the route of adaptation within the cystic fibrosis lung.

Identifiants

pubmed: 33720991
doi: 10.1371/journal.ppat.1009418
pii: PPATHOGENS-D-20-02557
pmc: PMC7993779
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009418

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203141/Z/16/Z
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
Nucleic Acids Res. 2017 Jul 3;45(W1):W30-W35
pubmed: 28472413
Nat Rev Microbiol. 2005 Feb;3(2):144-56
pubmed: 15643431
Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8266-71
pubmed: 27382184
Acta Clin Belg. 1996;51(4):222-30
pubmed: 8858887
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Front Microbiol. 2020 Sep 25;11:574626
pubmed: 33101250
PLoS Pathog. 2017 Dec 11;13(12):e1006762
pubmed: 29228063
Environ Microbiol Rep. 2017 Apr;9(2):55-70
pubmed: 28185400
Bioinformatics. 2015 Oct 15;31(20):3350-2
pubmed: 26099265
Nucleic Acids Res. 2014 Jan;42(Database issue):D7-17
pubmed: 24259429
G3 (Bethesda). 2020 Sep 2;10(9):2927-2939
pubmed: 32690586
Syst Appl Microbiol. 2013 Oct;36(7):483-9
pubmed: 23867250
Nat Commun. 2019 Jul 25;10(1):3313
pubmed: 31346170
Clin Infect Dis. 2001 Nov 1;33(9):1469-75
pubmed: 11588691
Respir Med. 1998 Feb;92(2):178-83
pubmed: 9616509
PLoS One. 2017 Apr 21;12(4):e0176191
pubmed: 28430818
J Clin Microbiol. 2005 Sep;43(9):4665-73
pubmed: 16145124
BMC Bioinformatics. 2010 Dec 10;11:595
pubmed: 21143983
Nucleic Acids Res. 2016 Aug 19;44(14):6614-24
pubmed: 27342282
Future Microbiol. 2007 Apr;2(2):153-64
pubmed: 17661652
Emerg Infect Dis. 2002 Feb;8(2):181-7
pubmed: 11897071
Nat Methods. 2018 Jun;15(6):461-468
pubmed: 29713083
J Cyst Fibros. 2008 Sep;7(5):368-72
pubmed: 18276200
J Clin Microbiol. 2003 Dec;41(12):5750-4
pubmed: 14662975
Nat Genet. 2011 Nov 13;43(12):1275-80
pubmed: 22081229
Emerg Microbes Infect. 2019;8(1):1186-1194
pubmed: 31381486
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Clin Microbiol Rev. 2011 Jan;24(1):29-70
pubmed: 21233507
J Clin Microbiol. 2009 Aug;47(8):2607-10
pubmed: 19494070
J Bacteriol. 2009 Jan;191(1):261-77
pubmed: 18931103
J Cyst Fibros. 2007 May;6(3):215-9
pubmed: 17141579
Thorax. 1995 Nov;50(11):1194-8
pubmed: 8553277
Genome Res. 2002 Oct;12(10):1611-8
pubmed: 12368254
Nucleic Acids Res. 2018 Jul 2;46(W1):W246-W251
pubmed: 29790974
mSystems. 2016 May 24;1(3):
pubmed: 27822534
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
J Clin Microbiol. 1999 Jul;37(7):2201-8
pubmed: 10364586
J Clin Microbiol. 2015 Jan;53(1):323-6
pubmed: 25392354
Emerg Infect Dis. 2007 Mar;13(3):458-61
pubmed: 17552100
Nat Genet. 2014 Jan;46(1):82-7
pubmed: 24316980
BMC Genomics. 2010 Oct 25;11:599
pubmed: 20973964
Nat Genet. 2015 Jan;47(1):57-64
pubmed: 25401299
Emerg Infect Dis. 2019 Jun;25(6):1084-1092
pubmed: 31107229
Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21
pubmed: 27141966
PLoS Pathog. 2018 Dec 7;14(12):e1007453
pubmed: 30532201
J Cyst Fibros. 2016 Nov;15(6):769-775
pubmed: 26996269
J Clin Microbiol. 2008 Jan;46(1):290-5
pubmed: 18032622
Bioinformatics. 2018 Aug 1;34(15):2666-2669
pubmed: 29547981
J Pediatr. 1984 Feb;104(2):206-10
pubmed: 6420530
Microb Genom. 2017 Nov;3(11):
pubmed: 29208140
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
J Clin Microbiol. 2010 Aug;48(8):2981-3
pubmed: 20519474
Eur Respir J. 2004 Jun;23(6):851-6
pubmed: 15218997
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Bioinformatics. 2017 Sep 15;33(18):2938-2940
pubmed: 28645171
Bioinformatics. 2007 Apr 15;23(8):1026-8
pubmed: 17309896
Clin Microbiol Rev. 2010 Apr;23(2):299-323
pubmed: 20375354
Antimicrob Agents Chemother. 2018 Aug 27;62(9):
pubmed: 29914964
J Clin Microbiol. 2013 Dec;51(12):3975-80
pubmed: 24048536
J Cyst Fibros. 2010 Dec;9(6):442-6
pubmed: 20833115
Environ Microbiol. 2005 Nov;7(11):1673-85
pubmed: 16232283
FEMS Microbiol Lett. 2003 Nov 7;228(1):57-62
pubmed: 14612237
Mol Biol Evol. 2017 Aug 1;34(8):2115-2122
pubmed: 28460117
J Clin Microbiol. 2004 Oct;42(10):4824-7
pubmed: 15472352
Nucleic Acids Res. 2019 Jul 2;47(W1):W81-W87
pubmed: 31032519

Auteurs

Cédric Lood (C)

Department of Biosystems, Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.
Department of Microbial and Molecular Systems, Centre of Microbial and Plant Genetics, Laboratory of Computational Systems Biology, KU Leuven, Leuven, Belgium.

Charlotte Peeters (C)

Belgian National Reference Centre for Burkholderia, Laboratory of Microbiology, Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, Ghent, Belgium.

Quentin Lamy-Besnier (Q)

Department of Biosystems, Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.

Jeroen Wagemans (J)

Department of Biosystems, Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.

Daniel De Vos (D)

Laboratory for Molecular and Cellular Technology (LabMCT), Queen Astrid Military Hospital, Brussels, Belgium.

Marijke Proesmans (M)

Department of Pediatrics, University Hospital Leuven, University of Leuven, Leuven, Belgium.

Jean-Paul Pirnay (JP)

Laboratory for Molecular and Cellular Technology (LabMCT), Queen Astrid Military Hospital, Brussels, Belgium.

Fedoua Echahidi (F)

Belgian National Reference Centre for Burkholderia, Department of Microbiology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Denis Piérard (D)

Belgian National Reference Centre for Burkholderia, Department of Microbiology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Matthieu Thimmesch (M)

Department of Pediatric Pneumology, CHC MontLégia, Liège, Belgium.

Anca Boeras (A)

Department of Microbiology, CHC MontLégia, Liège, Belgique.

Katrien Lagrou (K)

Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Clinical department of Laboratory Medicine, University Hospital Leuven, Leuven, Belgium.

Evelien De Canck (E)

Belgian National Reference Centre for Burkholderia, Laboratory of Microbiology, Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, Ghent, Belgium.

Elke De Wachter (E)

Department of Pediatric Pulmonology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Vera van Noort (V)

Department of Microbial and Molecular Systems, Centre of Microbial and Plant Genetics, Laboratory of Computational Systems Biology, KU Leuven, Leuven, Belgium.
Institute of Biology, Leiden University, Leiden, The Netherlands.

Rob Lavigne (R)

Department of Biosystems, Laboratory of Gene Technology, KU Leuven, Leuven, Belgium.

Peter Vandamme (P)

Belgian National Reference Centre for Burkholderia, Laboratory of Microbiology, Department of Biochemistry and Microbiology, Faculty of Sciences, Ghent University, Ghent, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH